- Presentations
- 2
- Markets
- 1
Zynrelef is a brand of Bupivacaine and Meloxicam marketed by Heron Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Bupivacaine and Meloxicam
- Brand owner
- Heron Therapeutics
- Registered in
- United States
- Strengths and forms
- 400 mg/12 mg per 14 mL injection, 65.7143 mg/1.97143 mg per 2.3 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Zynrelef 400 mg/12 mg per 14 mL injectionInfiltration | Heron Therapeutics | US FDA | Available on request |
| Zynrelef 65.7143 mg/1.97143 mg per 2.3 mL injectionInfiltration | Heron Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Zynrelef
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.